Protein kinase C mu selectively activates the mitogen-activated protein kinase (MAPK) p42 pathway

Area of Science:

• Cellular signaling pathways
• Molecular biology
• Signal transduction

Background:

• Protein kinase C mu (PKC mu) is a signaling enzyme implicated in various cellular processes.
• Mitogen-activated protein kinases (MAPKs) are crucial regulators of cell proliferation, differentiation, and survival.
• Understanding the cross-talk between different signaling pathways is essential for deciphering complex cellular functions.

Purpose of the Study:

• To investigate the role of human protein kinase C mu (PKC mu) in the activation of mitogen-activated protein kinase (MAPK).
• To elucidate the downstream targets and mechanisms by which PKC mu influences gene transcription.
• To determine the specificity of PKC mu-mediated MAPK activation within the broader MAPK family.

Main Methods:

• Transient expression of constitutively active PKC mu in cultured cells.
• In vitro kinase assays to assess Raf-1 and MAPK phosphorylation.
• Luciferase reporter gene assays to measure transcriptional activity driven by serum response elements (SREs).
• Inhibition studies using the MEK1 inhibitor PD98059.

Main Results:

• Constitutively active PKC mu activated Raf-1 kinase and subsequently MAPK.
• PKC mu enhanced transcriptional activity of an SRE-containing thymidine kinase promoter.
• Elk-1, a ternary complex factor, was identified as a key mediator of PKC mu-induced SRE transcriptional activation.
• PKC mu-mediated SRE-driven transcription was inhibited by PD98059, confirming MEK1 involvement.
• PKC mu specifically activated the p42/ERK1 MAPK cascade, without affecting c-jun N-terminal kinase or p38 MAPK.

Conclusions:

• Human PKC mu is an upstream activator of the p42/ERK1 MAPK cascade.
• PKC mu regulates gene transcription through the Elk-1 transcription factor and SRE elements.
• The findings highlight a specific role for PKC mu in regulating the ERK MAPK pathway, distinct from other MAPK family members.